Details of the Drug Combinations

General Information of This Drug (ID: DMJKHDL)

Drug Name

Ioversol DMJKHDL

Synonyms

ioversol; 87771-40-2; Optiray; Optiray 320; Ioversolum [Latin]; Optiray 240; Optiray 350; Optiray 160; MP-328; UNII-N3RIB7X24K; LOVERSOL; BRN 7155654; N3RIB7X24K; MP 328; 1,3-Benzenedicarboxamide, N,N'-bis(2,3-dihydroxypropyl)-5-((hydroxyacetyl)(2-hydroxyethyl)amino)-2,4,6-triiodo-; DSSTox_RID_80927; DSSTox_CID_25521; N,N'-Bis(2,3-dihydroxypropyl)-5-(N-(2-hydroxyethyl)glycolamido)-2,4,6-triiodoisophthalamide; DSSTox_GSID_45521; Optiray 300; Ioversolum

Indication

Disease Entry	ICD 11	Status	REF
Cardiovascular disease	BA00-BE2Z	Approved	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

1 Clinical Trial Drug Combination(s) Consisting of This drug

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
Iodixanol + Ioversol	DC2IDXR	Iodixanol	Hypothyroidism	[2]
------------------------------------------------------------------------------------

References

1	Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
2	ClinicalTrials.gov (NCT03631771) Pediatric Risk of Hypothyroidism With Iodinated Contrast Media